Dynamic changes of markers of endothelial function, hemostasis, fibrinolysis and inflammation in hospitalized patients with community-acquired pneumonia

K. Bielosludtseva (Dnipro, Ukraine), T. Pertseva (Dnipro, Ukraine), T. Kirieieva (Dnipro, Ukraine), M. Krykhtina (Dnipro, Ukraine)

Source: International Congress 2019 – Mechanisms underlying respiratory infection
Session: Mechanisms underlying respiratory infection
Session type: Poster Discussion
Number: 5452
Disease area: Respiratory infections

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
K. Bielosludtseva (Dnipro, Ukraine), T. Pertseva (Dnipro, Ukraine), T. Kirieieva (Dnipro, Ukraine), M. Krykhtina (Dnipro, Ukraine). Dynamic changes of markers of endothelial function, hemostasis, fibrinolysis and inflammation in hospitalized patients with community-acquired pneumonia. 5452

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Comparison of inflammatory response biomarkers to predict complications in hospitalized patients with community-acquired pneumonia
Source: Annual Congress 2011 - Biomarkers and outcomes of community-acquired pneumonia
Year: 2011

Impact of neutrophil function on outcomes of community-acquired pneumonia in patients with cancer
Source: Eur Respir Rev 2008; 17: 83-85
Year: 2008



Endothelial dysfunction and its corrections in patients with severe community-aquired pneumonia (CAP)
Source: Virtual Congress 2020 – Cardiovascular and pulmonary complications of respiratory infections
Year: 2020


The role of inflammatory parameters in the diagnosis and management of patients with community-acquired pneumonia
Source: Annual Congress 2012 - Management of pneumonia due to hospital pathogens
Year: 2012

Abnormal coagulation and fibrinolysis in relation to deterioration of pulmonary function in idiopathic interstitial pneumonia
Source: Annual Congress 2007 - Pathogenesis of idiopathic interstitial pneumonia including idiopathic pulmonary fibrosis
Year: 2007


Impact of neutrophil function on outcomes of community-acquired pneumonia (CAP) in patients with cancer
Source: Annual Congress 2007 - Community-acquired pneumonia: from aetiology to complication
Year: 2007


Enhanced PMN response in chronic bronchitis and community-acquired pneumonia
Source: Eur Respir J 2004; 24 : 772-778
Year: 2004



Initial and persistent inflammatory response in treatment failure in community-acquired pneumonia
Source: Annual Congress 2007 - Prognostic laboratory tests in community-acquired pneumonia
Year: 2007


Neutrophil extracellular traps levels are associated to severity and complications in community-acquired pneumonia
Source: Virtual Congress 2020 – Biomarkers and characterisation of immune response in respiratory infection
Year: 2020


The role of endothelin-1 in hospitalized patients with community-acquired pneumonia.
Source: International Congress 2019 – Mechanisms underlying respiratory infection
Year: 2019


Evolution of cytokines/chemokines in cases with severe nosocomial pneumonia and distinct etiologies in mechanical ventilated patients.
Source: Virtual Congress 2021 – Acute paediatric respiratory infections
Year: 2021


Changes in the vascular platelet phase of hemostasis in patients with septic and traumatic shock, presenting ARDS
Source: Eur Respir J 2004; 24: Suppl. 48, 264s
Year: 2004

Clinical pulmonary infection score (CPIS) and inflammatory response in patients with new pulmonary infiltrates and suspected ventilator acquired pneumonia (VAP)
Source: Annual Congress 2005 - Diagnosis and prognosis of ventilator associated pneumonia: the clinical track
Year: 2005


Clinical features and outcome of patients with acute exacerbation of interstitial pneumonia associated with collagen vascular disease
Source: Annual Congress 2010 - Clinical aspects in pulmonary fibrosis
Year: 2010

Regulation of PMN apoptosis in the airways during community acquired pneumonia in COPD patients and controls
Source: Annual Congress 2006 - Molecular airway biology
Year: 2006


Features of systemic inflammation in patients with severe community-acquired (CAP) pneumonia of different etiology in HIV-infected patients
Source: International Congress 2015 – Immunodepression and severe pneumonia
Year: 2015


The clinical significance of serum and bronchoalveoalr lavage inflammatory cytokine in patients with acute respiratory failure due to severe community-acquired pneumonia
Source: Eur Respir J 2006; 28: Suppl. 50, 347s
Year: 2006

Is it connection between systemic inflammation and risk of thrombotic disorders (by Padua scale) in hospitalized patients with community-acquired pneumonia (CAP)?
Source: International Congress 2018 – Predicting the future: biomarkers of respiratory infection
Year: 2018

Late-onset ventilator-associated pneumonia in patients with acute nervous system infections
Source: Annual Congress 2005 - Diagnosis and prognosis of ventilator associated pneumonia: the clinical track
Year: 2005


E-selectin as a prognostic factor of patients who hospitalized for respiratory inflammation diseases; a single institutional study
Source: International Congress 2016 – Clinical characteristics of asthma
Year: 2016